Last updated: 2026-09-23
Watch bacteria → right drug in about two hours — Tutorial
When a blood culture turns positive, watching how bacteria respond to antibiotics under a microscope can tell which drug will work in about two hours. A positive blood culture is a door, not the finish line. Watching how bacteria respond to antibiotics under a microscope can return a categorical right-drug-style map in about two hours after load for covered cases — with honest limits: clearance is not every lab’s shipping truck yet, and inventing stays open.
| Page | Title | Concept (one line) | When the tutor offers it | Illustration |
|---|---|---|---|---|
| 01 | Positive culture is not the finish line | A positive blood culture says something is growing — it still does not say which antibiotic will work. | First beat, before the watch-under-a-lens mechanism. | 01 |
| 02 | Watch how bacteria respond under a lens | A lab can expose living bacteria to antibiotics and watch how individual cells respond under a microscope. | After waiting-harm; before the two-hour one idea. | 02 |
| 03 | About two hours to a right-drug answer | When a blood culture turns positive, watching how bacteria respond to antibiotics under a microscope can tell which drug will work in about two hours. | Core one idea after the watch mechanism; before clock honesty. | 03 |
| 04 | Same-shift clock vs multi-day wait | The ~2-hour claim is the assay window after load — not bottle-to-positive time, not door-to-door sepsis care. | After the one idea; before computer-vision detail. | 04 |
| 05 | Computer vision is the reader | Computer vision scores the living-cell response pattern; it does not replace the phenotypic test or clinical judgment. | After clock honesty; before honest limits. | 05 |
| 06 | Cleared is not the same as ready to buy | Clearance ≠ commercial sale; Gram-negative monomicrobial window; still need a positive culture and a separate ID path. | After vision detail; before invent. | 06 |
| 07 | Invent an everyday change at Quickculture | Invent a useful new everyday hospital or community way that faster right-drug answers could change care. Leave the design open. | Last page / invent gate. | 07 |
Sources
- FDA Accessdata / 510(k) decision record — Class II automated antimicrobial susceptibility test system for positive blood culture samples; phenotypic video-microscopy pathway (decision Jun 2026)
- FDA 510(k) decision summary / indications language — phenotypic single-cell video microscopy; categorical interpretation; Gram-negative monomicrobial from positive blood cultures; organism ID from a separate cleared method
- Company / wire public announce of FDA clearance for rapid AST directly from positive blood cultures (23 Sep 2026; org self-report)
- Company site — assay windows about two hours after cartridge load; not currently available for commercial sale; Gram-negative panel limits (org self-report)
- FDA Breakthrough Devices Program public listing — marketing submission decision date Jun 2026 (designation ≠ clearance; clearance ≠ sale)